In 2023, Kimberly Blackwell, M.D. earned $4.88M in total compensation at Zentalis Pharmaceuticals, Inc., including $701.43K salary, $455.00K bonus and $3.71M in stock. Most recently acquired 250,000 shares in Feb 2024. Currently holds stock worth $702.01K. Led Zentalis Pharmaceuticals, Inc. as CEO for 2 years.
Compensation History
Annual executive compensation data for Kimberly Blackwell, M.D., including salary, bonuses, and stock awards.
Year
2023
Total Compensation
$4.88M
Salary
$701.43K
Bonus
$455.00K
Other
$17.08K
Salary
$701.43KBoard Justification
The compensation program links executive pay to company performance, with a significant portion of compensation at risk based on achievement of corporate performance goals.
Bonus
$455.00KBoard Justification
Annual cash bonus based entirely on the achievement of corporate performance goals for 2023, paid out at 100% of target.
Other Compensation
$17.08KBoard Justification
Includes cellular phone plan allowance, group term life insurance premiums, and 401(k) matching contributions.
Restricted Stock
Board Justification
RSUs vesting in four equal installments on each of the first four anniversaries of the grant date, subject to continued employment.
Performance Metrics
Corporate performance goals related to clinical development, future pipeline, financial objectives, and human capital management.
Kimberly Blackwell, M.D.
Ex-CEO of Zentalis Pharmaceuticals, Inc.
Education
M.D. from Mayo Clinic Medical School
Field of Expertise
Healthcare & Life Sciences - Medicine
Sector of Economy
Healthcare
Born
January 1, 1969 - 56 years ago
CEO of Zentalis Pharmaceuticals, Inc. for
2 years 5 months (May 2022 - Nov 2024)
Previous Experience
Chief Medical Officer at Tempus Labs
Other Zentalis Pharmaceuticals, Inc. CEOs
Holdings
Track Kimberly Blackwell, M.D.'s stock holdings and portfolio value over time.
Total Stock Sold
$313.63K
$313.63K
4,000 ZNTL shares
What if they kept their stock?
If Kimberly Blackwell, M.D. didn't sell their stock, today they would have:
Extra ZNTL4,000 shares worth $5.80K.
This is -98.15% and $307.83K less than what they got when they sold the stock.
Insider Trading
Kimberly Blackwell, M.D.'s recent stock transactions, purchases, and sales filed with the SEC.
250,000 shares
ZNTL
Feb 1, 2024
Received
$51.45K
ZNTL at $10.29/share
Nov 13, 2023
Purchase
244,800 shares
ZNTL
Feb 1, 2023
Received
$83.74K
ZNTL at $83.74/share
Jan 3, 2022
Sale
$81.84K
ZNTL at $81.84/share
Dec 1, 2021
Sale
$80.46K
ZNTL at $80.46/share
Nov 1, 2021
Sale
$77.59K
ZNTL at $77.59/share
Oct 25, 2021
Sale
5,000 shares
ZNTL
Jun 4, 2021
Received
Rivals
Compare Kimberly Blackwell, M.D. with competitor CEOs and industry peers.